BriaCell is an immuno-oncology-focused biotechnology company developing targeted and effective approaches for the management of cancer. Focusing initially on breast cancer, BriaCell Therapeutics Corp. is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.